MedTrace Logo

Getting Biased Treatment Study: How Psychotherapy and Antidepressants Change Brain Activity in Chronic Depression

NCT00596986 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2009-08-03

No results posted yet for this study

Summary

The purpose of this study is to determine how psychotherapy and pharmacotherapy respectively change brain activity in patients suffering from chronic depression.

Conditions

  • Chronic Depression

Interventions

DRUG

Duloxetine

Duloxetine 30mg up to 120mg per day.

BEHAVIORAL

Cognitive Behavioural Analysis System of Psychotherapy

Cognitive Behavioural Analysis System of Psychotherapy (CBASP): 20 sessions of psychotherapy, beginning with twice weekly, then weekly sessions.

Sponsors & Collaborators

  • German Federal Ministry of Education and Research

    collaborator OTHER_GOV

  • Charite University, Berlin, Germany

    lead OTHER

Principal Investigators

  • Isabella Heuser, Prof. Dr. med. Dipl. Psych. · Dept. of Psychiatry, Campus Benjamin Franklin, Charité Berlin, Germany

  • Michael Colla, Dr. med. · Department of Psychiatry, Campus Benjamin Franklin, Charité Berlin, Germany

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-10-31
Primary Completion
2009-09-30

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00596986 on ClinicalTrials.gov